Rxreliance

Peptide. Apelin 13 pyr1, Leu13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Thr12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7, Thr13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Thr13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Thr13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Thr13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, lle12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Asp6 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Thr12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, 12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, 12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, lle5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, lle5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Lys7, Thr12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6, Lys7, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Asp6, Thr12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, Asp6, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, dLeu5, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys4, dLeu5, Thr13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr12, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, Asp6, Thr12, Thr13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Lys3, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Lys3, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Asp5, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Asp5, des Pro12, des Phe13 Peptide , Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Lys6, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Lys6, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Lys3, Asp5, des Pro12, des Phe13 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 lle4, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 lle4, des Pro12, des Phe13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) 1-15 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) 7-84 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) 60-84 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) Rat 1-13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) Rat 2-13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) Rat 3-13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) Rat 4-13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Parathyroid hormone (pTH) Rat 5-13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. LL-37 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. LL-37, 7-37 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. LL-37, 14-34 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. GLP Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Myelin oligodendrocyte glycoprotein (MOG) Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Myelin oligodendrocyte glycoprotein (MOG) Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Ovalbumin, 323-339 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Ovalbumin, C-Nyps 323-339 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Ovalbumin, 257-264 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 21-44 K36Me3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 1-21 K9Me1 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 1-21 K9Me2 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 1-21 K9Me3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H4 Biotin Conjugated Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.